Review Article
New Evidence for Transmitter Role of VIP in The Airways: Impaired Relaxation by a Catalytic Antibody

https://doi.org/10.1006/pupt.2001.0337Get rights and content

Abstract

The identity of the transmitter(s) of nonadrenergic, noncholinergic airway smooth muscle relaxation has long been investigated. Recently, nitric oxide (NO) has been proposed as the main, if not the only transmitter. We earlier suggested vasoactive intestinal peptide (VIP) as a candidate transmitter and target for pathogenic catalytic autoantibodies (VIPases) found in certain humans. To re-examine the role of VIP, we studied the airway transport and effects of a model monoclonal antibody (Ab) capable of binding and cleaving VIP. In vitro receptor binding assays indicated the catalytic light chain subunit of the VIPase Ab to inhibit the saturable binding of (Tyr10-125I) VIP by guinea pig lung membranes, whereas a catalytically deficient mutant of the Ab light chain was without significant inhibitory activity. Systemically administered IgG preparations of the VIPase Ab accumulated in the airway lavage fluid of guinea pigs at levels close to those in blood, suggesting that the Ab reaches the airways freely. Electrical field stimulation (EFS)-induced relaxations of tracheal strips were weaker and shorter in VIPase-treated animals than in control nonimmune IgG-treated animals. The inhibitory effect of the VIPase was dose-dependent. VIPase-mediated inhibition of EFS-induced relaxation was evident both in the absence and presence of blockade of β-adrenergic and cholinergic receptors. Thus, circulating VIP binding and cleaving antibodies can reach the airways and attenuate the neurogenic relaxation of guinea pig tracheal smooth muscle, probably by neutralizing endogenously released VIP. The findings support a role for VIP as a major mediator of neurogenic relaxation of guinea pig tracheal smooth muscle. Lack of complete abrogation of relaxation is consistent with a co-transmitter role for NO.

References (32)

  • E Kubota et al.

    Vasoactive intestinal peptide as a possible transmitter of nonadrenergic, noncholinergic relaxation of pulmonary artery

    Trans Assoc Am Physicians

    (1985)
  • E Kubota et al.

    Autonomic innervation of pulmonary artery: evidence for a nonadrenergic noncholinergic inhibitory system

    Exp Lung Res

    (1988)
  • S Moncada et al.

    Nitric oxide: physiology, pathophysiology, and pharmacology

    Pharmacol Rev

    (1991)
  • SI Said

    Nitric oxide and vasoactive intestinal peptide as co-transmitters of smooth muscle relaxation

    News Physiol Sci

    (1992)
  • JR Grider et al.

    Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release

    Am J Physiol

    (1992)
  • TR Bai et al.

    Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi

    Am J Physiol

    (1993)
  • Cited by (42)

    • Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection

      2012, Journal of Biological Chemistry
      Citation Excerpt :

      Many examples of IgG and IgM class antibodies that catalyze the breakdown of peptide bonds in autoantigens have been reported (1–4). A single catalytic antibody molecule is reused to cleave multiple antigen molecules, and the cleavage reaction often results in permanent inactivation of the antigen (5–7). If combined with the traditional ability to recognize antigenic epitopes with sufficient noncovalent binding affinity, the proteolytic function acquires specificity for individual antigens.

    • Catalytic antibodies to HIV: Physiological role and potential clinical utility

      2008, Autoimmunity Reviews
      Citation Excerpt :

      The protective effects of infusion of IgG from uninfected monkeys against SIV [34] and of pooled IgG from uninfected humans (IVIG) against HIV has been investigated [35]. Proteolytic Igs inactivate antigens irreversibly and with potency superior to conventional Igs [36]. Catalytic salivary IgAs from uninfected humans neutralized primary, R5-dependent clade B and C strains.

    View all citing articles on Scopus
    f1

    Correspondence to: Sami I. Said, M.D., Pulmonary and Critical Carre Medicine, HSC T17-040, SUNY at Stony Brook, Stony Brook, NY 11794-8172.Tel: 631444-1754; Fax: 631444-7502; E-mail: [email protected]

    View full text